Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Anti-PD-1 or anti-CTLA-4 in first line therapy?

Prof Claus Garbe - University of Tübingen, Tübingen, Germany
Anti-PD-1 or anti-CTLA-4 in first line therapy? ( Prof Claus Garbe - University of Tübingen, Tübingen, Germany )
5 Nov 2015

Long response and long responders in melanoma immunology

Prof Georgina Long - University of Sydney, Sydney, Australia
Long response and long responders in melanoma immunology ( Prof Georgina Long - University of Sydney, Sydney, Australia )
5 Nov 2015

Progress in targeted therapy of melanoma

Prof Keith Flaherty - Massachusetts General Hospital, Boston, USA
Progress in targeted therapy of melanoma ( Prof Keith Flaherty - Massachusetts General Hospital, Boston, USA )
5 Nov 2015

Metastatic melanoma: Patient-reported outcomes from the KEYNOTE-002 study

Prof Dirk Schadendorf - University of Duisburg-Essen, Essen, Germany
Metastatic melanoma: Patient-reported outcomes from the KEYNOTE-002 study ( Prof Dirk Schadendorf - University of Duisburg-Essen, Essen, Germany )
5 Nov 2015

Management of acute metastatic melanoma

Dr Paul Lorigan - The Christie NHS Foundation Trust, Manchester, UK
Management of acute metastatic melanoma ( Dr Paul Lorigan - The Christie NHS Foundation Trust, Manchester, UK )
5 Nov 2015

How should we handle talimogene laherparepvec (T-VEC)?

Prof Axel Hauschild - University of Kiel, Kiel, Germany
How should we handle talimogene laherparepvec (T-VEC)? ( Prof Axel Hauschild - University of Kiel, Kiel, Germany )
5 Nov 2015

New challenges in drug combination and strategies

Dr Paul Lorigan - The Christie NHS Foundation Trust, Manchester, UK
New challenges in drug combination and strategies ( Dr Paul Lorigan - The Christie NHS Foundation Trust, Manchester, UK )
5 Nov 2015

Editor's choice for October 2015

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
Editor's choice for October 2015 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
4 Nov 2015

Targeting N-RAS mutated tumours

Prof Axel Hauschild - University of Kiel, Kiel, Germany
Targeting N-RAS mutated tumours ( Prof Axel Hauschild - University of Kiel, Kiel, Germany )
30 Oct 2015

HVEM expression in melanoma metastasis: prognosis correlation

Prof Daniel Olive - Marseilles Cancer Research Center, Marseilles, France
HVEM expression in melanoma metastasis: prognosis correlation ( Prof Daniel Olive - Marseilles Cancer Research Center, Marseilles, France )
30 Oct 2015

Vemurafenib in patients with BRAF600 mutation–positive metastatic melanoma

Prof Axel Hauschild - University of Kiel, Kiel, Germany
Vemurafenib in patients with BRAF600 mutation–positive metastatic melanoma ( Prof Axel Hauschild - University of Kiel, Kiel, Germany )
30 Oct 2015

ASTRO 2015 highlights: UK perspective

Dr Ajay Aggarwal – London School of Hygiene and Tropical Medicine, London, UK
ASTRO 2015 highlights: UK perspective ( Dr Ajay Aggarwal – London School of Hygiene and Tropical Medicine, London, UK )
27 Oct 2015